Association between 5HT2A polymorphism and selective serotonin re-uptake inhibitor (SSRI)-induced sexual desire disorder (SDD) among Malaysian women

Asia-Pacific Psychiatry

Volumn 5, Issue SUPPL. 1, 2013, Pages 41-49

  Masiran, Ruziana ^a   Sidi, Hatta ^a   Mohamed, Zahurin ^b   Mohamed Saini, Suriati ^a   Nik Jaafar, Nik Ruzyanei ^a  

^a Hospital Kebangsaan Malaysia   (Malaysia)

^b UNIVERSITY OF MALAYA   (Malaysia)

Author keywords

5HT2A polymorphism; Major depressive disorder; Selective serotonin re uptake inhibitor induced female sexual dysfunction; Sexual desire disorder

Indexed keywords

SEROTONIN; SEROTONIN UPTAKE INHIBITOR;

ARTICLE; CROSS-SECTIONAL STUDY; EMPLOYMENT STATUS; FEMALE; FEMALE SEXUAL DYSFUNCTION; GENETIC ASSOCIATION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALAYSIA; MARRIAGE; ORGASM DISORDER; PRIORITY JOURNAL; SEXUAL AROUSAL DISORDER; SEXUAL DESIRE DISORDER; SEXUAL SATISFACTION; SEXUALITY; SIDE EFFECT; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT DURATION; VAGINAL LUBRICATION;

5HT2A POLYMORPHISM; MAJOR DEPRESSIVE DISORDER; SELECTIVE SEROTONIN RE-UPTAKE INHIBITOR-INDUCED FEMALE SEXUAL DYSFUNCTION; SEXUAL DESIRE DISORDER;

ADULT; CROSS-SECTIONAL STUDIES; DEPRESSIVE DISORDER, MAJOR; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALAYSIA; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PREVALENCE; PSYCHIATRIC STATUS RATING SCALES; QUESTIONNAIRES; RECEPTOR, SEROTONIN, 5-HT2A; SEROTONIN UPTAKE INHIBITORS; SEXUAL DYSFUNCTIONS, PSYCHOLOGICAL;

EID: 84876466941     PISSN: 17585864     EISSN: 17585872     Source Type: Journal    
DOI: 10.1111/appy.12043     Document Type: Article

References (26)

1. Abdel-Hamid I.A., Andersson K.-E. (2009) Pharmacogenetics and pharmacogenomics of sexual dysfunction: current status, gaps and potential applications. Pharmacogenomics. 10, 1225-1244.
2. American Psychiatric Association (2000) Diagnostic and Statistical Manual of Mental Disorders, 4th edn. Text Rev. American Psychiatric Association, Washington, DC.
3. Balon R. (2006) SSRI-associated sexual dysfunction. Am J Psychiatry. 163, 1504-1509.
4. Bishop J.R., Moline J., Ellingrod V.L., Schultz S.K., Clayton A.H. (2006) Serotonin 2A-1438 G/A and G-protein Beta3 subunit C825T polymorphisms in patients with depression and SSRI-associated sexual side-effects. Neuropsychopharmacology. 31, 2281-2288.
5. Bloch M.H., McGuire J., Landeros-Weisenberger A., Leckman J.F., Pittenger C. (2010) Meta-analysis of the dose-response relationship of SSRI in obsessive-compulsive disorder. Mol Psychiatry. 15, 850-855.
6. Burri A., Spector T. (2011) Recent and lifelong sexual dysfunction in a female UK population sample: prevalence and risk factors. J Sex Med. 8, 2420-2430.
7. Clayton A.H., Pradko J.F., Croft H.A., etal. (2002) Prevalence of sexual dysfunction among newer antidepressants. J Clin Psychiatry. 63, 357-366.
8. Corona G., Ricca V., Bandini E., etal. (2009) Selective serotonin reuptake inhibitor-induced sexual dysfunction. J Sex Med. 6, 1259-1269.
9. Csoka A., Bahrick A., Mehtonen O.-P. (2008) Persistent sexual dysfunction after discontinuation of selective serotonin reuptake inhibitors. J Sex Med. 5, 227-233.
10. Hatta S., Norni A., Sharifah Ezat W.P., Marhani M. (2007a) The female sexual function index (FSFI): validation of the Malay version. J Sex Med. 4, 1642-1654.
11. Hatta S., Sharifah Ezat W.P., Marhani M., Norni A. (2007b) Sexual arousal problem among Malaysian women in a primary care setting. Malays J Psychiatry. 16, 3-10.
12. Hatta S., Sharifah Ezat W.P., Norni A., Marhani M. (2007c) The prevalence of sexual dysfunction and potential risk factors that may impair sexual function in Malaysian women. J Sex Med. 4, 311-321.
13. Hatta S., Duni A., Rozita H., Ng C.G. (2012a) Female sexual dysfunction in patients treated with antidepressant - comparison between escitalopram and fluoxetine. J Sex Med. 9, 1392-1399.
14. Hatta S., Duni A., Rozita H., Nik Ruzyanei J., Ng C.G. (2012b) Hypoactive sexual desire among depressed female patients treated with selective serotonin reuptake inhibitors: a comparison between escitalopram and fluoxetine. Int J Psychiatry Clin Pract. 16, 41-47.
15. Ishak I.H., Low W.Y., Othman S. (2010) Prevalence, risk factors and predictors of female sexual dysfunction in a primary care setting: a survey finding. J Sex Med. 7, 3080-3087.
16. Laumann E.O., Paik A., Rosen R.C. (1999) Sexual dysfunction in the United States: prevalence and predictors. JAMA. 281, 537-544.
17. Ministry of Health Malaysia (2007) Clinical practice guidelines management of major depressive disorder. 5-7. [Cited 14 August 2010.] Available from URL: http://www.moh.gov.my
18. Montejo-González A.L., Llorca G., Izquierdo J.A., etal. (1997) SSRI-induced sexual dysfunction: fluoxetine, paroxetine, sertraline, and fluvoxamine in a prospective, multicenter, and descriptive clinical study of 344 patients (Abstract). J Sex Marital Ther. 23, 176-194.
19. Osis L., Bishop J.R. (2010) Pharmacogenetics of SSRIs and sexual dysfunction. Pharmaceuticals. 3, 3614-3628.
20. Rosen R., Brown C., Heiman J., etal. (2000) The female sexual function index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther. 26, 191-208.
21. Rust J., Golombok S., Collier J. (1988) Marital problems and sexual dysfunction: how are they related? Br J Pychiatry. 152, 629-631.
22. Serretti A., Chiesa A. (2009) Treatment-emergent sexual dysfunction related to antidepressants. A meta-analysis. J Clin Psychopharmacol. 29, 259-266.
23. Stahl S.M. (2001) The psychopharmacology of sex, part 2: effects of drugs and disease on the 3 phases of Human sexual response. J Clin Psychiatry. 62, 147-148.
24. Strohmaier J., Wust S., Uher R., etal. (2011) Sexual dysfunction during treatment with serotonergic and noradrenergic antidepressants: clinical description and the role of the 5-HTTLPR. World J Biol Psychiatry. 12, 528-538. Early Online: 1-11.
25. Waldinger M.D., Olivier B. (1998) Selective serotonin reuptake inhibitor-induced sexual dysfunction: clinical and research considerations. Int Clin Psychopharmacol. 13(Suppl 6), S27-S33.
26. Zimmerman M., Posternak M.A., Iwona C. (2004) Derivation of a definition of remission on the Montgomery-Asberg depression rating scale corresponding to the definition of remission on the Hamilton rating scale for depression (Abstract). J Psychiatr Res. 38, 577-582.